The global pharmaceutical landscape has shifted dramatically in 2026, with the Biologics Market reaching a staggering valuation of $534.3 billion. This year, the industry is witnessing a fierce technological tug-of-war between expression systems. While microbial sources historically dominated due to their speed, 2026 has seen the "Mammalian Segment" surge with a 11.0% CAGR, driven by the...